Tox Pearls are one-page clinical insights from Dr. William Bundy Jr., PharmD — each covering a single toxicology concept that matters in practice. Free to download, share, and use. Written for clinicians and programs, published on LinkedIn.
Each pearl covers a single clinical insight in depth — no filler, no padding. Designed to be read in under five minutes and applied the same day.
No paywall, no login required. Download for your program, share with colleagues, or print for patient education — no permission needed.
Every pearl cites primary literature. Findings are translated into direct clinical language — what it means, and what to do with it.
Tox Pearls exist because clinicians, drug court staff, and OTP programs often need fast, authoritative answers to complex toxicology questions. The literature is there; the time to read it usually is not.
Each pearl translates a specific, evidence-based concept into a one-page document you can read in the time it takes to walk to the next exam room. Shareable, citable, and free by design.
Follow Dr. Bundy on LinkedIn →When to trust an immunoassay, when to order confirmation, and how to explain discrepant results to patients and courts.
Practical guidance on medication selection, duration, adherence monitoring, and the science behind treatment decisions.
Novel opioids, xylazine analogues, and other emerging threats — what they are, how they present, and what standard panels miss.
When a pearl warrants full clinical reference depth, it connects to the corresponding Tox In Focus volume for the complete picture.
Each issue of ToxSignal goes deeper — emerging drug threats, regulatory changes, and practice-relevant science, delivered free to your inbox. Tox Pearls and Tox In Focus volumes are always linked from inside each issue.
The clinical toxicology newsletter — drug trends, regulatory updates, and practice-relevant science, delivered free.
No spam. Unsubscribe anytime.